Usefulness of argon plasma coagulation for superficial esophageal squamous cell neoplasia in patients at high risk or with limited endoscopic resectability | Zendy

Yo Kubota | Zendy; Satoshi Tanabe | Zendy; Kenji Ishido | Zendy; Takafumi Yano | Zendy; Takuya Wada | Zendy; Akinori Watanabe | Zendy; Mizutomo Azuma | Zendy; Chikatoshi Katada | Zendy; Wasaburo Koizumi | Zendy

Open Access

Usefulness of argon plasma coagulation for superficial esophageal squamous cell neoplasia in patients at high risk or with limited endoscopic resectability

Author(s) -

Yo Kubota,

Satoshi Tanabe,

Kenji Ishido,

Takafumi Yano,

Takuya Wada,

Akinori Watanabe,

Mizutomo Azuma,

Chikatoshi Katada,

Wasaburo Koizumi

Publication year - 2020

Publication title -

the turkish journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.404

H-Index - 28

eISSN - 2148-5607

pISSN - 1300-4948

DOI - 10.5152/tjg.2020.19329

Subject(s) - medicine , argon plasma coagulation , adverse effect , surgery , chemoradiotherapy , endoscopy , radiation therapy

Endoscopic resection is the standard treatment for superficial esophageal squamous-cell neoplasia (SESCN). However, we encounter patients in whom endoscopic resection is difficult to perform. We retrospectively studied the usefulness of argon plasma coagulation (APC) in patients with SESCN.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research